Macrophage inflammatory protein-1-alpha

Drug Profile

Macrophage inflammatory protein-1-alpha

Alternative Names: LD 78; MIP-1 alpha

Latest Information Update: 29 Jan 2015

Price : $50

At a glance

  • Originator Wyeth
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Chemoprotection

Most Recent Events

  • 11 Oct 2000 No-Development-Reported for Chemotherapy induced damage/Chemoprotection in USA (Unknown route)
  • 23 Oct 1998 A preclinical study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top